Natural compounds regulate the PI3K/Akt/GSK3β pathway in myocardial ischemia-reperfusion injury

被引：18
|
作者：
Ajzashokouhi, Amir Hossein [1 ]
Rezaee, Ramin [2 ,3 ]
Omidkhoda, Navid [4 ]
Karimi, Gholamreza [5 ,6 ,7 ]
机构：
[1] Mashhad Univ Med Sci, Sch Pharm, Mashhad, Iran
[2] Mashhad Univ Med Sci, Int UNESCO Ctr Hlth Related Basic Sci & Human Nutr, Mashhad, Iran
[3] Mashhad Univ Med Sci, Appl Biomed Res Ctr, Mashhad, Iran
[4] Mashhad Univ Med Sci, Sch Pharm, Dept Clin Pharm, Mashhad, Iran
[5] Mashhad Univ Med Sci, Sch Pharm, Dept Pharmacodynam & Toxicol, Mashhad, Iran
[6] Mashhad Univ Med Sci, Pharmaceut Technol Inst, Pharmaceut Res Ctr, Mashhad, Iran
[7] Mashhad Univ Med Sci, Inst Pharmaceut Technol, Pharmaceut Res Ctr, Mashhad, Iran
来源：
CELL CYCLE | 2023年 / 22卷 / 07期
关键词：
PI3K/Akt/GSK3 beta pathway; ischemia-reperfusion; injury; cardiomyocyte; natural compounds; apoptosis; ACTIVATED PROTEIN-KINASE; INDUCED CARDIAC-HYPERTROPHY; GLYCOGEN-SYNTHASE KINASE-3-BETA; PERMEABILITY TRANSITION PORE; COLON-CANCER CELLS; SALVIANOLIC ACID B; PROLONGS LIFE-SPAN; HIGH-FAT DIET; ISCHEMIA/REPERFUSION INJURY; ASTRAGALOSIDE-IV;
D O I：
10.1080/15384101.2022.2161959
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
The PI3K/Akt/GSK3 beta pathway is crucial in regulating cardiomyocyte growth and survival. It has been shown that activation of this pathway alleviates the negative impact of ischemia-reperfusion. Glycogen synthase kinase-3 (GSK3 beta) induces apoptosis through stimulation of transcription factors, and its phosphorylation has been suggested as a new therapeutic target for myocardial ischemia-reperfusion injury (MIRI). GSK3 beta regulatory role is mediated by the reperfusion injury salvage kinase (RISK) pathway, and its inhibition by Akt activation blocks mitochondrial permeability transition pore (mPTP) opening and enhances myocardial survival. The present article discusses the involvement of the PI3K/Akt/GSK3 beta pathway in cardioprotective effects of natural products against MIRI.
引用
收藏
页码：741 / 757
页数：17
相关论文
共 50 条
  • [1] Bisoprolol, a β1 antagonist, protects myocardial cells from ischemia-reperfusion injury via PI3K/AKT/GSK3β pathway
    Wang, Jing
    Liu, Jing
    Xie, Liang
    Cai, Xiaomin
    Ma, Xiaohua
    Gong, Jianbin
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2020, 34 (06) : 708 - 720
  • [2] The role of PI3K/AKT signaling pathway in myocardial ischemia-reperfusion injury
    Deng, Rui-ming
    Zhou, Juan
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 123
  • [3] Sevoflurane Alleviates Myocardial Ischemia-Reperfusion Injury in Rats by Reducing Oxidative Stress and Activating PI3K/Akt/GSK3β Signaling Pathway
    Zhang, Zhengbing
    Luo, Chunfang
    Wan, Caiyun
    Xu, Kai
    Huang, Fang
    Feng, Yinghui
    Li, Ming
    Min, Wei
    LATIN AMERICAN JOURNAL OF PHARMACY, 2020, 39 (02): : 394 - 400
  • [4] Morphine Reduces Myocardial Apoptosis in Rats with Myocardial Ischemia-Reperfusion Injury Through PI3K/Akt/GSK-3β Pathway
    Ren, Yuhua
    Liu, Yuzhi
    Yang, Yong
    Zhang, Yanmin
    Zhang, Shaoyang
    PANMINERVA MEDICA, 2020,
  • [5] Dexmedetomidine reduces myocardial ischemia-reperfusion injury in rats through PI3K/AKT/GSK-3β signaling pathway
    Zhang, Xiushuang
    Xu, Mingjun
    Che, Xiangming
    Cao, Xiuling
    Li, Xiaoguang
    MINERVA CARDIOANGIOLOGICA, 2020, 68 (01): : 58 - 59
  • [6] Glutamine protects myocardial ischemia-reperfusion injury in rats through the PI3K/Akt signaling pathway
    Cui, Z-H
    Zhang, X-J
    Shang, H-Q
    Wang, X.
    Rong, D.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (01) : 444 - 451
  • [7] Syringic acid mitigates myocardial ischemia reperfusion injury by activating the PI3K/Akt/GSK-3β signaling pathway
    Liu, Gen
    Zhang, Bo-fang
    Hu, Qi
    Liu, Xiao-pei
    Chen, Jing
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 531 (02) : 242 - 249
  • [8] Kaempferide Protects against Myocardial Ischemia/Reperfusion Injury through Activation of the PI3K/Akt/GSK-3β Pathway
    Wang, Dong
    Zhang, Xinjie
    Li, Defang
    Hao, Wenjin
    Meng, Fanqing
    Wang, Bo
    Han, Jichun
    Zheng, Qiusheng
    MEDIATORS OF INFLAMMATION, 2017, 2017
  • [9] PI3K/AKT pathway: A potential therapeutic target in cerebral ischemia-reperfusion injury
    Han, Yiming
    Sun, Yu
    Peng, Shiyu
    Tang, Tingting
    Zhang, Beibei
    Yu, Ruonan
    Sun, Xiaoyan
    Guo, Shanshan
    Ma, Lijuan
    Li, Peng
    Yang, Pengfei
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2025, 998
  • [10] Urolithin A alleviates myocardial ischemia/reperfusion injury via PI3K/Akt pathway
    Tang, Lu
    Mo, Yingli
    Li, Yunpeng
    Zhong, Yongkang
    He, Shangfei
    Zhang, Ya
    Tang, Ying
    Fu, Shanshan
    Wang, Xianbao
    Chen, Aihua
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 486 (03) : 774 - 780
12345